Medibank Private

Medibank operates a balance-sheet investment portfolio funded by premium float from its core health insurance operations. This portfolio holds direct real estate — such as the Myhealth Medical Clinics portfolio and iMH Deakin Private Hospital — alongside defensive assets in Australia and a global growth allocation. The investment team deploys capital directly rather than entirely through external fund managers, giving the insurer an operating-company-like exposure to healthcare real assets.

CEO David Koczkar oversees the group's capital allocation strategy, with Mark Rogers serving as CFO and Group Strategy lead. The investment function sits inside the broader Medibank Group rather than in a separately branded asset-management entity. The firm does not publicly name a standalone CIO, consistent with its structure as a corporate insurer managing treasury and investment in-house.

Medibank directly owns its head office at Medibank Place, 695 Collins Street, and a second office at 720 Bourke Street, both in Melbourne's Docklands. It also holds a national portfolio of Myhealth Medical Clinics and is the joint venture partner in iMH Deakin Private Hospital in Canberra, developed alongside Aurora Healthcare Australia. These holdings sit on the defensive-asset side of the internal portfolio.

No. Medibank Private is a publicly listed health insurer on the Australian Securities Exchange, not a single-family or multi-family office. It manages a corporate investment portfolio for the benefit of its balance sheet and indirectly its shareholders, rather than for a single family or group of families.

The investment portfolio is split between defensive assets held in Australia and growth assets with a global mandate. Known exposures include direct commercial real estate (offices and medical clinics), hospital infrastructure, private credit, and public equities. The firm does not publicly disclose a detailed asset-class breakdown, but its direct-property positions and joint ventures indicate a blend of alternatives and traditional exposures.

The Medibank Better Health Research Hub functions as a philanthropic vehicle funding applied health research. It operates independently of the commercial insurance and investment arms, though it sits under the Medibank Group umbrella. There is no evidence that Hub funds flow into the investment portfolio or that the investment team manages its endowment.

Publicly available information does not clarify whether Medibank commits to third-party funds or only pursues direct investments. The directly held property and joint venture positions point to a direct-deal orientation for real assets, but the global growth portfolio may include fund commitments. The company has not disclosed a formal allocation framework.